Primary Antibodies

View as table Download

C1QA goat polyclonal antibody, FITC

Applications ELISA, ID, IF, IHC, IP
Reactivities Human
Conjugation FITC
Immunogen The subunit C1q is isolated as a homogenous protein for use in antiserum production.
Freund’s complete adjuvant is used in the first step of the immunization.

Complement C3 (C3) goat polyclonal antibody, Biotin

Applications ELISA, ID, IF, IHC, IP, WB
Reactivities Human
Conjugation Biotin
Immunogen C3c is isolated and purified from pooled normal human serum by precipitation techniques, followed by chromatographical methods.
Freund’s complete adjuvant is used in the first step of the immunization.

Complement C3 (C3) goat polyclonal antibody, TRITC

Applications ELISA, ID, IF, IHC, IP
Reactivities Human
Conjugation TRITC
Immunogen C3c is isolated and purified from pooled normal human serum.
Freund’s complete adjuvant is used in the first step of the immunization.

Complement C5 (C5) goat polyclonal antibody, FITC

Applications ELISA, ID, IF, IHC, IP
Reactivities Human
Conjugation FITC
Immunogen C5 protein isolated and purified from pooled normal human serum.
Freund’s complete adjuvant is used in the first step of the immunization

C1R goat polyclonal antibody, Serum

Applications ID, IP
Reactivities Human
Immunogen The subunit C1r is isolated as a homogenous protein for use in antiserum production.
Freund’s complete adjuvant is used in the first step of the immunization.

C1S goat polyclonal antibody, Serum

Applications ID, IP
Reactivities Human
Immunogen The subunit C1s is isolated as a homogenous protein for use in antiserum production.
Freund’s complete adjuvant is used in the first step of the immunization.

Complement factor B (CFB) goat polyclonal antibody, Serum

Applications ID, IHC, IP
Reactivities Human
Immunogen Isolated as a homogenous protein for use in antiserum production.
Freund’s complete adjuvant is used in the first step of the immunization procedure.

Complement C3 (C3) goat polyclonal antibody, Serum

Applications ID, IHC, IP
Reactivities Human
Immunogen The protein is isolated and purified from pooled normal human serum by precipitation techniques, followed by chromatographical methods.
Freund’s complete adjuvant is used in the first step of the immunization.

Plasminogen (PLG) goat polyclonal antibody, Serum

Applications ID, IP, R
Reactivities Human
Immunogen Native plasminogen is a single polypeptide chain, synthesized in the liver. Its molecular weight has been reported to be 81,000 and 92,000. Part of the molecule contains the active serine esterase of plasmin. On activation it is converted to two polypeptide chains linked by disulphide bridges. Three different abnormal molecular forms of plasminogen have been described. Normal adult plasma contains 10-20 mg/100 ml plasminogen. Different congenital molecular structure abnormalities associated with recurrent thrombosis have been described, but are extremely rare. In liver disease plasminogen activity may be reduced. Freund’s complete adjuvant is used in the first step of the immunization procedure.

C1QA goat polyclonal antibody, Serum

Applications ID, IP
Reactivities Human
Immunogen The subunit C1q is isolated as a homogenous protein for use in antiserum production.
Freund’s complete adjuvant is used in the first step of the immunization.

Complement C3 (C3) goat polyclonal antibody, Serum

Applications ID, IP
Reactivities Human
Immunogen Isolated and purified from pooled normal human serum by precipitation techniques, followed by chromatographical methods.
Freund’s complete adjuvant is used in the first step of the immunization.

Complement C4A (C4A) goat polyclonal antibody, Serum

Applications ID, IP
Reactivities Human
Immunogen The C4 protein is isolated as a homogenous protein for use in antiserum production.
Freund’s complete adjuvant is used in the first step of the immunization procedure.

Complement C5 (C5) goat polyclonal antibody, Serum

Applications ID, IP
Reactivities Human
Immunogen C5 protein is isolated as a homogenous protein for use in antiserum production.
Freund’s complete adjuvant is used in the first step of the immunization

SERPING1 goat polyclonal antibody, Serum

Applications ID, IP
Reactivities Human
Immunogen Freund’s complete adjuvant is used in the first step of the immunization procedure.

Factor XI (F11) goat polyclonal antibody, Serum

Applications ID, IP
Reactivities Human
Immunogen Plasma FXI.
Freund’s complete adjuvant is used in the first step of the immunization.

Kininogen 1 (KNG1) (LMW Isoform) goat polyclonal antibody, Serum

Applications ID, IP
Reactivities Human
Immunogen Highly purified Molecular Weight Kininogen isolated from pooled plasma.
Freund’s complete adjuvant is used in the first step of the immunization procedure.

Protein S (PROS1) goat polyclonal antibody, Serum

Applications ID, IP
Reactivities Human
Immunogen Freund’s complete adjuvant is used in the first step of the immunization procedure.

Alpha 2 Antiplasmin (SERPINF2) goat polyclonal antibody, Serum

Applications ID, IP
Reactivities Human
Immunogen Apha-2 antiplasmin is a single-chain glycoprotein with a molecular weight of about 65,000. The normal concentration in human plasma is 60 μg/ml. Platelets contain significant amounts of the protein, which is released along with platelet factor 4, following thrombin stimulation. It can form 1:1 complexes with circulating plasmin. Alpha-2 antiplasmin is the most important inhibitor of plasmin-mediated fibrinolysis, but also capable of inactivating factor XIIa, kallikrein, factor XIa, thrombin and factor Xa. The importance of the alpha-2 antiplasmin as regulator of the fibrinolytic system was detected by the discovery of a congenital deficiency. Alpha-2 antiplasmin has been isolated from pooled plasma. Freund’s complete adjuvant is used in the first step of the immunization procedure.

Kininogen 1 (KNG1) goat polyclonal antibody, Serum

Applications ID, IP
Reactivities Human
Immunogen Purified Kininogen from pooled Human plasma is used for the immunization.
Freund’s complete adjuvant is used in the first step of the immunization procedure.